Humana Inc (NYSE:HUM) insider M Todoroff Christopher sold 16,389 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $273.37, for a total transaction of $4,480,260.93. Following the sale, the insider now owns 13,447 shares of the company’s stock, valued at approximately $3,676,006.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Humana Inc (NYSE HUM) traded up $0.52 during trading hours on Wednesday, hitting $270.50. 739,694 shares of the stock were exchanged, compared to its average volume of 1,105,778. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.48. Humana Inc has a 12 month low of $203.48 and a 12 month high of $293.35. The firm has a market cap of $36,928.31, a price-to-earnings ratio of 22.94, a P/E/G ratio of 1.46 and a beta of 0.95.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The business had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. During the same quarter in the previous year, the business earned $2.34 earnings per share. The firm’s revenue was up 2.4% compared to the same quarter last year. equities analysts forecast that Humana Inc will post 13.81 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.74%. The ex-dividend date is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio is currently 9.59%.
Humana announced that its board has approved a stock buyback program on Thursday, December 14th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the insurance provider to purchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.
A number of research analysts have issued reports on the stock. Zacks Investment Research cut shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. JPMorgan Chase & Co. raised their price objective on shares of Humana from $253.00 to $271.00 and gave the stock a “neutral” rating in a research note on Monday, February 12th. Deutsche Bank raised their price objective on shares of Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a research note on Friday, February 9th. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 target price on the stock in a research report on Friday, January 12th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $230.00 target price on shares of Humana in a research report on Tuesday, December 5th. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Humana presently has a consensus rating of “Buy” and an average price target of $270.47.
A number of hedge funds have recently bought and sold shares of the business. Advantus Capital Management Inc grew its position in Humana by 1.4% in the third quarter. Advantus Capital Management Inc now owns 14,798 shares of the insurance provider’s stock worth $3,605,000 after acquiring an additional 203 shares in the last quarter. Cadence Capital Management LLC boosted its holdings in shares of Humana by 3.6% during the 3rd quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock worth $1,434,000 after buying an additional 205 shares during the period. Daiwa SB Investments Ltd. boosted its holdings in shares of Humana by 44.9% during the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock worth $176,000 after buying an additional 220 shares during the period. HL Financial Services LLC boosted its holdings in shares of Humana by 2.1% during the 4th quarter. HL Financial Services LLC now owns 11,205 shares of the insurance provider’s stock worth $2,780,000 after buying an additional 230 shares during the period. Finally, Mackenzie Financial Corp boosted its holdings in shares of Humana by 3.6% during the 3rd quarter. Mackenzie Financial Corp now owns 6,642 shares of the insurance provider’s stock worth $1,618,000 after buying an additional 232 shares during the period. 97.85% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://ledgergazette.com/2018/03/14/insider-selling-humana-inc-hum-insider-sells-16389-shares-of-stock.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.